Kenvue Inc. (KVUE) fair value analysis
S&P 500 · Updated 2026-09-07
Kenvue Inc. is a consumer health company that manufactures and markets over-the-counter medicines, vitamins, and personal care products sold under well-known brand names. The company operates globally, selling its products across North America, Europe, Asia, and other international markets.
Forward Fair Value verdict
Fairly valuedBased on TickrTrends' weekly Forward Fair Value model, KVUE is trading at within about 10% of estimated fair value.
KVUE currently ranks #37 of 64 Consumer Defensive stocks by discount to Forward Fair Value. It has screened as Fairly valued for 3 consecutive weekly runs.
- Last price
- $18.74
- Sector
- Consumer Defensive
- 12-month range
- $14.37–$19.24
Derived indicators
Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.
- Quality grade
- D
- Leverage
- Moderate
- Margin trend
- Stable
- Revenue growth
- Modest
- RSI zone
- Neutral
- 52-week position
- The top quarter of its range
- DCF cross-check
- Overvalued
What our data shows for KVUE
- Our model validated 12 trailing price-to-earnings windows for KVUE, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $14.37–$19.24.
- The 14-day relative strength index sits at a neutral 40.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for KVUE
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.
What people are saying
Follow the KVUE conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-06 — TickrTrends' momentum indicator for KVUE has changed from an A rating to none this week, reflecting a shift in the stock's directional strength. With the current valuation verdict remaining at fairly valued, the stock's technical momentum characteristics have deteriorated compared to the prior week's assessment.
- 2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is KVUE stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), KVUE is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.
What is KVUE's TickrTrends verdict?
KVUE's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.
How does KVUE compare to other Consumer Defensive stocks?
KVUE ranks #37 of 64 Consumer Defensive stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.
Is KVUE overbought or oversold?
KVUE's 14-day RSI is in neutral territory - neither overbought nor oversold.
More in Consumer Defensive
Head-to-head comparisons
KVUE vs ANDE · KVUE vs APEI · KVUE vs CENT · KVUE vs CENTA · KVUE vs CL